Effect of botulinum D toxin on human neutrophilic leukocytes and localization of its substrates.
Botulinum D toxin has been shown to ADP-ribosylate 22-kD proteins in neutrophilic leukocytes, but the function of these GTP-binding proteins remains unknown. In analogy to small GTP-binding proteins like SEC4 to YPT1, it has been suggested that botulinum D toxin substrates might be involved in secretory process of myeloid cells. Three main findings lead to the opposite conclusion. First of all, in human neutrophils, botulinum D toxin does not modify the release of azurophilic and specific granules induced by a chemoattractant (a formylpeptide) or a phorbol ester. Second, botulinum D toxin ADP-ribosylates 24 to 26-kD proteins that are only present in plasma membranes of human neutrophils. The membrane location of these substrates differs largely from that of the GTP-binding proteins involved in exocytosis and located in granules. Finally, since the same quantity of the toxin substrates is present in neutrophils as in their precursors, HL60 cells (which are devoid of specific granules and characterized by immature azurophilic granules and NADPH oxidase), it is unlikely that endogenous botulinum D toxin substrates are directly involved in the secretory responses of neutrophils.
Andre
P
P
Laboratoire d'Immunologie, Hôpital de Sainte-Marguerite, Marseille, France.
Capo
C
C
Fossat
C
C
Bongrand
P
P
Mege
J L
JL
D001905:Botulinum Toxins / Q000494:pharmacology*; D002458:Cell Fractionation; D002478:Cells, Cultured; D003594:Cytoplasmic Granules / Q000378:metabolism; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D012266:Ribose / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D014407:Tumor Cells, Cultured
D008565:Membrane Proteins; D013481:Superoxides; D012266:Ribose; D001905:Botulinum Toxins